0001701959-18-000001.txt : 20180124 0001701959-18-000001.hdr.sgml : 20180124 20180124142331 ACCESSION NUMBER: 0001701959-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180124 DATE AS OF CHANGE: 20180124 EFFECTIVENESS DATE: 20180124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MicrobeDx, Inc. CENTRAL INDEX KEY: 0001701959 IRS NUMBER: 810832019 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-303980 FILM NUMBER: 18544852 BUSINESS ADDRESS: STREET 1: 17866 TRAMONTO DRIVE CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 BUSINESS PHONE: 7175141491 MAIL ADDRESS: STREET 1: 17866 TRAMONTO DRIVE CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 D 1 primary_doc.xml X0708 D LIVE 0001701959 MicrobeDx, Inc. 104 San Andreas Drive Navato CA CALIFORNIA 94945 (416)678-0928 DELAWARE None None Corporation true 2015 Bernard M. Churchill 104 San Andreas Drive Navato CA CALIFORNIA 94945 Executive Officer Director Michael Churchill 104 San Andreas Drive Navato CA CALIFORNIA 94945 Executive Officer Director James Ratner 104 San Andreas Drive Navato CA CALIFORNIA 94945 Director David Haake 104 San Andreas Drive Navato CA CALIFORNIA 94945 Executive Officer Director Chuck Blevin 104 San Andreas Drive Navato CA CALIFORNIA 94945 Executive Officer Biotechnology Decline to Disclose 06b false 2018-01-09 true true true true true Each unit will be comprised of one $1,000 principal amount secured convertible debenture and 1,852 common share purchase warrants each entitling the holder to acquire one share of common stock at $0.54, exercisable within 5 years of issuance. false 0 5000200 2500000 2500200 The additional $2,500,200 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. false 14 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false MicrobeDx, Inc. Michael Churchill Michael Churchill CFO 2018-01-20